- Home
- CAPR vs GUT Comparison
CAPR vs GUT Comparison
Compare CAPR & GUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- GUT
- Stock Information
- Founded
- CAPR 2005
- GUT 1999
- Country
- CAPR United States
- GUT United States
- Employees
- CAPR N/A
- GUT N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- GUT Trusts Except Educational Religious and Charitable
- Sector
- CAPR Health Care
- GUT Finance
- Exchange
- CAPR Nasdaq
- GUT Nasdaq
- Market Cap
- CAPR 332.5M
- GUT 398.9M
- IPO Year
- CAPR N/A
- GUT N/A
- Fundamental
- Price
- CAPR $17.79
- GUT $5.32
- Analyst Decision
- CAPR Strong Buy
- GUT
- Analyst Count
- CAPR 7
- GUT 0
- Target Price
- CAPR $39.29
- GUT N/A
- AVG Volume (30 Days)
- CAPR 1.1M
- GUT 176.3K
- Earning Date
- CAPR 11-13-2024
- GUT 01-01-0001
- Dividend Yield
- CAPR N/A
- GUT 10.93%
- EPS Growth
- CAPR N/A
- GUT N/A
- EPS
- CAPR N/A
- GUT N/A
- Revenue
- CAPR $23,228,045.00
- GUT N/A
- Revenue This Year
- CAPR N/A
- GUT N/A
- Revenue Next Year
- CAPR $135.53
- GUT N/A
- P/E Ratio
- CAPR N/A
- GUT N/A
- Revenue Growth
- CAPR 65.33
- GUT N/A
- 52 Week Low
- CAPR $2.90
- GUT $4.60
- 52 Week High
- CAPR $23.40
- GUT $7.38
- Technical
- Relative Strength Index (RSI)
- CAPR 47.77
- GUT 61.07
- Support Level
- CAPR $17.21
- GUT $4.97
- Resistance Level
- CAPR $19.47
- GUT $5.40
- Average True Range (ATR)
- CAPR 1.64
- GUT 0.09
- MACD
- CAPR -0.38
- GUT 0.05
- Stochastic Oscillator
- CAPR 28.33
- GUT 80.23
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
About GUT Gabelli Utility Trust (The)
Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.